Literature DB >> 33633112

PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.

Ning Wang1, Hor-Yue Tan1, Yuanjun Lu1, Yau-Tuen Chan1, Di Wang2, Wei Guo1, Yu Xu1, Cheng Zhang1, Feiyu Chen1, Guoyi Tang1, Yibin Feng3.   

Abstract

Altered energy metabolism of cancer cells shapes the immune cell response in the tumor microenvironment that facilitates tumor progression. Herein, we reported the novel of tumor cell-expressed Piwi Like RNA-Mediated Gene Silencing 1 (PIWIL1) in mediating the crosstalk of fatty acid metabolism and immune response of human hepatocellular carcinoma (HCC). PIWIL1 expression in HCC was increased compared to normal hepatic tissues and was positively correlated with the proliferation rate of HCC cell lines. PIWIL1 overexpression accelerated in vitro proliferation and in vivo growth of HCC tumors, while PIWIL1 knockdown showed opposite effects. PIWIL1 increased oxygen consumption and energy production via fatty acid metabolism without altering aerobic glycolysis. Inhibition of fatty acid metabolism abolished PIWIL1-induced HCC proliferation and growth. RNA-seq analysis revealed that immune system regulation might be involved, which was echoed by the experimental observation that PIWIL1-overexpressing HCC cells attracted myeloid-derived suppressor cells (MDSCs) into the tumor microenvironment. MDSCs depletion reduced the proliferation and growth of PIWIL1-overexpressing HCC tumors. Complement C3, whose secretion was induced by PIWIL1 in HCC cells, mediates the interaction of HCC cells with MDSCs by activated p38 MAPK signaling in MDSCs, which in turn initiated expression of immunosuppressive cytokine IL10. Neutralizing IL10 secretion reduced the immunosuppressive activity of MDSCs in the microenvironment of PIWIL1-overexpressing HCC. Taken together, our study unraveled the critical role of PIWIL1 in initiating the interaction of cancer cell metabolism and immune cell response in HCC. Tumor cells-expressed PIWIL1 may be a potential target for the development of novel HCC treatment.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33633112      PMCID: PMC7907082          DOI: 10.1038/s41392-021-00485-8

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN: 2059-3635


  78 in total

1.  Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.

Authors:  Xiu Hua Yang; Satoshi Yamagiwa; Takafumi Ichida; Yasunobu Matsuda; Satoshi Sugahara; Hisami Watanabe; Yoshinobu Sato; Toru Abo; David A Horwitz; Yutaka Aoyagi
Journal:  J Hepatol       Date:  2006-03-09       Impact factor: 25.083

2.  Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α.

Authors:  An Xu; Bibo Wang; Jing Fu; Wenhao Qin; Ting Yu; Zhishi Yang; Qingjun Lu; Jingyi Chen; Yao Chen; Hongyang Wang
Journal:  Cancer Lett       Date:  2018-10-26       Impact factor: 8.679

3.  HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection.

Authors:  Yi-Ming Zhao; Jia-Min Zhou; Long-Rong Wang; Hong-Wei He; Xi-Long Wang; Zhong-Hua Tao; Hui-Chuan Sun; Wei-Zhong Wu; Jia Fan; Zhao-You Tang; Lu Wang
Journal:  Cancer       Date:  2011-10-11       Impact factor: 6.860

4.  Hiwi downregulation, mediated by shRNA, reduces the proliferation and migration of human hepatocellular carcinoma cells.

Authors:  Yingjun Xie; Yongsheng Yang; Degang Ji; Dan Zhang; Xiaoxiao Yao; Xuewen Zhang
Journal:  Mol Med Rep       Date:  2014-11-03       Impact factor: 2.952

5.  Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression.

Authors:  Yu Wang; Sheng-Nan Sun; Qing Liu; Yang-Yang Yu; Jian Guo; Kun Wang; Bao-Cai Xing; Qing-Feng Zheng; Michael J Campa; Edward F Patz; Shi-You Li; You-Wen He
Journal:  Cancer Discov       Date:  2016-06-13       Impact factor: 39.397

Review 6.  Fatty acid oxidation: An emerging facet of metabolic transformation in cancer.

Authors:  Yibao Ma; Sarah M Temkin; Adam M Hawkridge; Chunqing Guo; Wei Wang; Xiang-Yang Wang; Xianjun Fang
Journal:  Cancer Lett       Date:  2018-08-10       Impact factor: 8.679

7.  Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice.

Authors:  Jiwon Yang; Hye-Na Ahn; Minsun Chang; Purnima Narasimhan; Pak H Chan; Yun Seon Song
Journal:  J Neurochem       Date:  2012-12-28       Impact factor: 5.372

8.  Myeloid suppressor cell depletion augments antitumor activity in lung cancer.

Authors:  Minu K Srivastava; Li Zhu; Marni Harris-White; Upendra K Kar; Upendra Kar; Min Huang; Ming F Johnson; Jay M Lee; David Elashoff; Robert Strieter; Steven Dubinett; Sherven Sharma
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

9.  Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma.

Authors:  Stéphanie Lacotte; Florence Slits; Lorenzo A Orci; Jeremy Meyer; Graziano Oldani; Vaihere Delaune; Carmen Gonelle-Gispert; Philippe Morel; Christian Toso
Journal:  Oncoimmunology       Date:  2016-09-20       Impact factor: 8.110

10.  PIWIL1/piRNA-DQ593109 Regulates the Permeability of the Blood-Tumor Barrier via the MEG3/miR-330-5p/RUNX3 Axis.

Authors:  Shuyuan Shen; Hai Yu; Xiaobai Liu; Yunhui Liu; Jian Zheng; Ping Wang; Wei Gong; Jiajia Chen; Lini Zhao; Yixue Xue
Journal:  Mol Ther Nucleic Acids       Date:  2017-12-30       Impact factor: 8.886

View more
  4 in total

Review 1.  Inside-Out of Complement in Cancer.

Authors:  Martin Kolev; Madhumita Das; Monica Gerber; Scott Baver; Pascal Deschatelets; Maciej M Markiewski
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

Review 2.  Lactate: The Mediator of Metabolism and Immunosuppression.

Authors:  Yuanyuan Zhang; Zhao Zhai; Jiali Duan; Xiangcai Wang; Jinghua Zhong; Longqiu Wu; An Li; Miao Cao; Yanyang Wu; Huaqiu Shi; Jianing Zhong; Zhenli Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 3.  Elevated P-Element-Induced Wimpy-Testis-Like Protein 1 Expression Predicts Unfavorable Prognosis for Patients with Various Cancers.

Authors:  Kehua Jiang; Tao Ye; Juan Du; Lanlan Tang; Xiaolong Chen; Fa Sun; Xifeng Sun
Journal:  J Oncol       Date:  2021-12-31       Impact factor: 4.375

Review 4.  Epigenetic remodelling in human hepatocellular carcinoma.

Authors:  Maria Rita Braghini; Oriana Lo Re; Ilaria Romito; Maite G Fernandez-Barrena; Barbara Barbaro; Silvia Pomella; Rossella Rota; Manlio Vinciguerra; Matias A Avila; Anna Alisi
Journal:  J Exp Clin Cancer Res       Date:  2022-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.